CCC Critical Care compendium 340
Sugammadex CCC

Sugammadex is used for reversal of the amino steroid neuromuscular blocking drugs rocuronium, vecuronium and pancuronium.

CCC Critical Care compendium 340
Terlipressin

Terlipressin: synthetic vasopressin analogue with relative specificity for the splanchnic circulation where it causes vasoconstriction in these vessels with a reduction in portal pressure.

CCC Critical Care compendium 340
Tirofiban

Tirofiban: anti-platelet agent; glycoprotein IIb/IIIa antagonist -> stops platelet aggregation

CCC Critical Care compendium 340
Cervical artery dissection

Cervical artery dissections is the collective term for dissections of the carotid or vertebral arteries. They are important causes of stroke in younger people and are often difficult diagnoses to make

CCC Critical Care compendium 340
Practice Misalignment

Practice misalignment occurs in RCTs when randomization disrupts the normal relationship between clinically important characteristics and therapy titration. This can create subgroups of patients within each study arm that receive levels of therapy that are inconsistent with current practices outside of the clinical study and may be harmful

CCC Critical Care compendium 340
Delirium in ICU

Peer reviewed by Maurice Le Guen OVERVIEW SIGNIFICANCE In adult ICU patients: PATHOPHYSIOLOGY RISK-FACTORS Baseline In ICU ASSESSMENT Clinical presentation Assessment approach Delirium monitoring Tools MANAGEMENT Early recognition Non-pharmacologic treatment Pharmacologic treatment EVIDENCE Treatment Page VJ, et al.  2013 Devlin JW,…

CCC Critical Care compendium 340
Interruptions of Sedation

Daily Interruptions of Sedation in Mechanically Ventilated Patients designed to reduce exposure to sedative agents; allow assessment of neurological status; assess readiness for extubation; and reduce duration of mechanical ventilation

CCC Critical Care compendium 340
Acute Respiratory Distress Syndrome – ARDS

OVERVIEW DEFINITION The Berlin Definition (2013) SEVERITY  ARDS Severity   PaO2/FiO2*   Mortality**  Mild 200 – 300 27% Moderate 100 – 200 32% Severe < 100 45% *on PEEP 5+; **observed in cohort RISK FACTORS Direct Indirect PATHOPHYSIOLOGY Classical phases Complex interplay:…